← All indications
Cardiovascular Diseases
Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
Subtype terms (5)
More specific conditions that are subtypes of Cardiovascular Diseases in the MeSH hierarchy.
- Cardiovascular Abnormalities
25 drugs (17 approved, 8 experimental)
- Cardiovascular Infections
- Heart Diseases
425 drugs (278 approved, 147 experimental)
- Pregnancy Complications, Cardiovascular
- Vascular Diseases
205 drugs (142 approved, 63 experimental)
Drugs by status
Approved for this indication (31)
- flavonoids
- iodixanol
- l-epigallocatechin
- iopamidol
- iopromide
- beetroot juice
- soybean
- prasugrel
- cocoa extract
- iohexol
- pomegranate
- ximingting
- resveratrol
- omega-6 fatty acids
- genistein
- chuanxiong
- atorvastatin
- cod liver oil
- evolocumab
- danhong
- pravastatin
- simvastatin
- crataegus
- linoleic acid
- yangxinshi
- telmisartan
- xuefu zhuyu
- propanolol
- xuezhikang
- hydroxytyrosol
- +1 more
Phase 4 trials (167)
- tipranavir
- leuprolide
- sofosbuvir
- sacubitril
- dapagliflozin
- nebivolol
- pioglitazone
- chlorhexidine
- insulin detemir
- velpatasvir
- ezetimibe
- tenofovir
- tildrakizumab
- acetylsalicylic acid
- nitroglycerin
- nelfinavir
- lamivudine
- naproxen
- stavudine
- exenatide
- allopurinol
- valsartan
- nesiritide
- sterculia gum
- tacrolimus
- empagliflozin
- loperamide
- degarelix acetate
- elbasvir
- vitamin d3
- +137 more
Phase 3 trials (118)
- alagebrium
- phytosterol
- sotalol
- disopyramide
- felodipine
- quinidine
- olive
- carotene
- alteplase
- imipramine
- digoxin
- azithromycin
- evacetrapib
- streptokinase
- methylprednisolone
- fondaparinux sodium
- colestipol
- plantago ovata
- estrogen
- dextrothyroxine
- heparin
- aln-agt01
- alirocumab
- procainamide
- egg
- reserpine
- laropiprant
- amiodarone
- perindopril
- insulin human
- +88 more
Phase 2 trials (82)
- roxadustat
- citrulline
- 13c-pyruvate
- pea
- ceftriaxone
- indapamide
- pentoxifylline
- regadenoson
- delcasertib
- nitric oxide
- pc-mab
- gemfibrozil
- covaccine
- apelin
- deferoxamine
- relaxin
- alfacalcidol
- apabetalone
- puerarin
- nt-0796
- spermidine
- lumasiran
- ranibizumab
- blueberry allergenic extract
- ferumoxytol
- curcumin
- sodium nitrite
- cherry
- apple
- cyclodextrin
- +52 more
Phase 1 trials (84)
- elafibranor
- azd5718
- n-omega-nitro-l-arginine methyl ester
- fx-5a peptide complex
- zinc gluconate
- chlorophyll complex
- 99mtccabvcam1-5
- Balcinrenone
- dabigatran
- ringer's lactate
- medi6570
- cholic acid
- cardiac stem cells
- poppy seed
- cantharidin
- pyridoxamine
- fluconazole
- tetrahydrobiopterin
- lipopolysaccharide
- black currant
- flavanol
- bq-123
- oricar-017
- wobenzyme
- meijiao
- losmapimod
- mrg-110
- thiamine
- zamicastat
- phenylephrine
- +54 more
Other trials (163)
- calcium carbonate
- rutin
- urocortin 3
- sodium nitrate
- canola oil
- 11-octadecenoic acid
- paclitaxel
- wolfberry
- seaweed
- fructose
- atropine
- tomato
- duloxetine
- milrinone
- chokeberry extract
- ginseng
- pantoprazole
- 7-methylxanthine
- albuterol
- ketone monoester
- fluvoxamine
- oryza sativa
- beta-glucans
- tyrosol
- sapropterin
- whey protein
- linseed oil
- iqp-as-118
- bacopa monnieri
- edoxaban
- +133 more
Organizations
Organization Involved with Phase 4 Indications (222)
- Orion Corporation
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- National Institute for Health Research, United Kingdom
- Erasmus University Rotterdam
- Abant Izzet Baysal University
- GlaxoSmithKline
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- People's Liberation Army of China
- Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
- Acerus Pharmaceuticals Corporation
- The Physicians' Services Incorporated Foundation
- British Heart Foundation
- Lepu Medical Technology (Beijing) Co., Ltd.
- Chinese Society of Cardiology
- Synmosa Biopharma Corp.
- Hospital Universitario Arnau de Vilanova de Lleida
- Steno Diabetes Center Copenhagen
- Herlev Hospital
- COLM Study Research Organization
- Keio University
- Duke University
- Garvan Institute of Medical Research
- University of Western Ontario
- Boehringer Ingelheim
- National Heart, Lung, and Blood Institute (NHLBI)
- Yamaguchi University
- Ohio State University
- University of Tehran
- University of Monastir
- King Fahad Armed Forces Hospital
- +192 more
Organization Involved with Phase 3 Indications (212)
- Ogden Research Foundation
- ECRI bv
- University of Miami
- Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental
- Nabi Biopharmaceuticals
- NSABP Foundation
- University of Nebraska
- Statistics and Epidemiology Research Corporation
- Anand, Sonia, M.D.
- Dutch Heart Foundation
- Florida Department of Citrus
- Scripps
- Palo Alto Medical Research Foundation
- University of Durham
- Government of India
- Henry Ford Health System
- Mauritius Ministry of Health and Quality of Life
- The TIMI Study Group
- Clinical Trials & Surveys Corp
- Novartis
- Centers for Disease Control and Prevention (CDC)
- Rottapharm
- Epsom and St Helier University Hospitals NHS Trust
- Geisinger Clinic
- East Kent Hospitals University NHS Foundation Trust
- French Cardiology Society
- Semmelweis University
- Maryland Medical Research Institute
- Utrecht University
- Government of Brazil
- +182 more
Organization Involved with Phase 2 Indications (73)
- Albany College of Pharmacy and Health Sciences
- Government of Spain
- University of Lyon
- Clinical Data, Inc.
- Hospital General Universitario Morales Meseguer
- Cherry Research Committee
- KAI Pharmaceuticals
- Factor Therapeutics Ltd.
- Encorium
- Invitrox
- XyloCor Therapeutics, Inc.
- AMAG Pharmaceuticals, Inc.
- Hoosier Cancer Research Network
- Renal Research Institute
- University of Bergen
- Cumberland Pharmaceuticals
- Fundacion Investigacion y Desarrollo
- California Walnut Commission
- Vanderbilt University
- University of Oslo
- Sarepta Therapeutics
- Barts & The London NHS Trust
- Parexel
- Grenoble Alps University
- Illumina, Inc.
- MedImmune
- University of Calgary
- The Campbell Foundation
- Canola Council of Canada
- University of Manchester
- +43 more
Organization Involved with Phase 1 Indications (39)
- University of Arizona
- University of Texas, Arlington
- California Clinical Trials
- Chonbuk National University
- Chungnam National University
- Sanford-Burnham Medical Research Institute
- University of Reading
- Cytori Therapeutics
- Biosearch S.A.
- Guangzhou Yipinhong Pharmaceutical CO.,LTD
- Peanut Institute
- Bial
- Quotient
- University of Louisville
- Queen's University, Belfast
- Pharmacia
- Government of Malaysia
- National University of Singapore
- Bastyr University
- Platelet and Thrombosis Research L.L.C
- New Haven Pharmaceuticals, Inc.
- Naturalpha
- Hospital Universitario San Cecilio
- Servier
- Genfit
- Laval University
- Asklepion
- Rockefeller University
- Guizhou Meijiao Co., Ltd
- Technical University of Munich
- +9 more
Organization Involved with Other Experimental Indications (150)
- Prostate Cancer Canada Network
- University of Talca
- Welch Foods Incorporated
- Finnish Cultural Foundation
- Unilever
- Creighton University
- Trinity College Dublin
- Almond Board of California
- Eastern Mediterranean University
- Clinical Hospital Center Zemun
- Provident Clinical Research
- Cancer Research Network
- Friedrich Schiller University
- University of Lorraine
- Slovak Academy of Sciences
- University of Aberdeen
- Rajiv Gandhi University of Health Sciences
- Hebei University
- Western Galilee Hospital
- Government of Finland
- New York City Clinical Data Research Network
- Ubonratchathani Cancer Hospital
- Soremartec Italia S.r.l.
- Soy Nutrition Institute
- Eurecat
- TERRES INOVIA
- Government of Hong Kong
- Arla Foods
- Albert Einstein Israelite Hospital
- The Alfred Hospital
- +120 more